clinical trial · NCT02735083
A Study to Evaluate the Long-term Safety of Patients With Advanced Lymphoid Leukemia Who Have Been Previously Administered With UCART19
Institut de Recherches Internationales Servier·phase1·active not recruiting·n = 28
Advanced Lymphoid LeukemiaUCART19 follow-up
brief summary
The purpose of this study is to evaluate the long-term safety and efficacy of UCART19 administration to patients with advanced lymphoid leukemia.
started
Mar 10, 2021
primary completion
Sep 1, 2028
completion
Sep 1, 2028
last updated
Apr 11, 2025
official title
Long-term Follow-up Study of Patients Who Have Previously Been Exposed to UCART19 (Allogeneic Engineered T-cells Expressing a Lentiviral-based Anti-CD19 Chimeric Antigen Receptor)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol